<h1>Liver diagnostics firm opens regional headquarters to expand FibroScan access, training, and dealer network across multiple countries</h1> A non-invasive liver diagnostics company opened a regional headquarters in Mumbai to coordinate operations across South Asia, aiming to expand access to its FibroScan device in India, Bangladesh, Bhutan, Maldives, Nepal, and Sri Lanka. The office will manage sales, distribution, distributor support, training and education with over 30 local dealer partners. The move is positioned as a strategic response to rising metabolic dysfunction-associated steatotic liver disease and obesity-related liver conditions-prevalence estimates cited for adults and children in India and higher rates among people with type 2 diabetes-intending to improve early detection and monitoring.